HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price target from $45 to $30.
An expert analyst still believes in Tyra Biosciences but thinks the stock is worth less money than before. You can watch if other experts agree or disagree to understand if the company is facing real problems.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.